Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Hoffman, Motonori Akahori, Bernard King.

Premium

Stephen Hoffman has joined Celera Genomics as senior vice president, immunotherapeutics. He will establish and lead a new team to identify disease targets using the company’s genomics and proteomics data.

Hoffman came to Celera from the US Navy, where he directed malaria research efforts. He played a key role in sequencing the genome of Plasmodium falciparum, the microbe responsible for malaria.

Hoffman and his team will initially focus on specific cancers, with the goal of developing vaccines, therapeutics, and small-molecules for treatment and prevention of the disease.

Genomic Solutions has promoted Motonori Akahori to president of its Japanese subsidiary, Genomic Solutions KK. Formerly general manager of the subsidiary, Akahori founded the Japan office of the company’s predecessor, B.I. Systems.

Akahori will serve a major role in identifying global product opportunities for Genomic Solutions.

Clinical bioinformatics company Pioneer has appointed Bernard King as president and CEO. King held a number of positions prior to joining the company, including president and COO of Advanced Bioresearch Associates, president of ChromoXome, and executive vice president for biological sciences and medical affairs at Trega Biosciences.

Filed under

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.